Arterial occlusions as a presenting feature of acute promyelocytic leukemia

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 21, Issue 5, 1998, Pages 436-437

  Rolston, David D K ^a   Rubin, Stephen ^a   Topolsky, David ^a   Styler, Michael ^a   Crilley, Pamela ^a,b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Division of Hematology   (United States)

Author keywords

Acute promyelocytic leukemia; Arterial thrombosis; Pulmonary emboli

Indexed keywords

CEFUROXIME; ERYTHROMYCIN; HEPARIN; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ARTERY OCCLUSION; ARTICLE; CASE REPORT; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PNEUMONIA; SURGICAL ANATOMY;

ADOLESCENT; HUMANS; ILIAC ARTERY; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; PULMONARY EMBOLISM; THROMBOSIS;

EID: 0031785463     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199810000-00002     Document Type: Article

References (7)

1. Warrell RP, de The H, Wang ZY, Degos L. Acute promyelocytic leukemia. N Engl J Med 1993;329:177-89.
2. Avvisati G, Cate JWT, Mandalli F. Acute promyelocytic leukemia. Br J Haematol 1992;81:315-20.
3. Tallman MS, Kwaan HC. Reassessing the haemostatic disorder associated with acute promyelocytic leukemia. Blood 1990; 79:543-53.
4. Marialuisa D, Giovanni C, Alessandro D, Castelli F, Giacomo C, Alberto D. Occlusion of the carotid artery as presenting symptom of acute promyelocytic leukemia. Arch Suisses Neurol Psych 1991;142:307-11.
5. Fass R, Haddad M, Zaizov R, et al. Recurrent peripheral arterial occlusion by leukemic cells sedimentation in acute promyelocytic leukemia. J Pediatr Surg 1992;27:665-7.
6. Saiitoh E, Sugita K, Kurosawa H, et al. Cerebral infarction in acute promyelocytic leukemia at initial presentation. Acta Paediatr Jpn 1995;37:710-2.
7. Quadir TA, Dhabhar BN, Dhar AK, Hedge UP, Shah RV, Pathak AB, Advani SH. Acute promyelocytic leukemia with ischemic events. J Assoc Physicians India 1993;41:300-2.